AGN Market Cap History
Below is a table of the AGN market cap history going back to 10/17/2013:

Date AGN Market Cap
10/17/201325.56B
2/7/201432.79B
4/18/201434.43B
7/18/201457.66B
5/1/2015113.71B
7/31/2015130.35B
10/29/2015119.96B
2/15/2016110.70B
5/2/201686.27B
8/3/201699.99B
10/26/201683.26B
2/17/201782.92B
5/3/201781.87B
7/28/201784.58B
10/27/201759.47B
2/13/201852.43B
4/27/201854.94B
7/30/201862.45B
10/26/201859.77B
2/8/201943.94B
5/3/201947.80B
8/6/201952.32B
12/6/20137.97B
11/1/201958.53B
2/12/202066.49B
4/27/202062.08B

Also see: AGN Shares Outstanding History
and AGN YTD Return
AGN Historical Market Cap:
+14.55% CAGR
AGN Historical Market Cap: +14.55% CAGR

Mouse over chart for data details
10/17/2013 ...4/27/2020
Allergan is a pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical, device, biologic, surgical and regenerative medicine products for patients around the world. Co. has three segments: United States Specialized Therapeutics, which includes products within the United States, including Medical Aesthetics, Medical Dermatology Eye Care and Neuroscience and Urology therapeutic products; United States General Medicine, which includes products within the United States that do not fall into the United States Specialized Therapeutics business units, including Central Nervous System; and International, which includes products sold outside the United States. We show 26 historical shares outstanding datapoints in our AGN shares outstanding history coverage, used to compute AGN market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AGN market cap history over the course of time is important for investors interested in comparing AGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AGN versus a peer is one thing; comparing AGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AGN can fluctuate over the course of history. With this page we aim to empower investors researching AGN by allowing them to research the AGN market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for AGN:
AGN SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Allergan (AGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

AGRX Market Cap History
AGTC Market Cap History
AHPI Market Cap History
AIMT Market Cap History
AIQ Market Cap History
AKAO Market Cap History
AKBA Market Cap History
AKCA Market Cap History
AKER Market Cap History
AKRX Market Cap History
More Healthcare companies »

 

AGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.